BrainStorm Cell Therapeutics Inc. , a leading developer of cellular therapies for neurodegenerative diseases, today announced its participation in the 4th Annual ALS Drug Development Summit, to take ...

Neurological disorders such as Alzheimer’s and Parkinson’s may be linked to the brain’s reduced ability to clear harmful ...

The biotech’s Huntingtin-targeting molecule lowered blood levels of the protein and elicited functional improvements in ...

New 20-year study reveals that rare CNS infections in kidney transplant recipients carry high mortality and long-term ...

Hallucinations, cortical visual loss, advanced brain atrophy, and a normal CSF white blood cell count are tied to rapidly ...

The four anti-CD20 drugs used in the U.S. to treat relapsing MS -- ocrelizumab, ofatumumab, and ublituximab (Briumvi; ...

Scientists have discovered that the same device used to measure C-reactive protein (CRP) in blood to diagnose bacterial ...

Detection of neural autoantibodies with accurate laboratory assays in patients with compatible clinical-MRI phenotypes allows ...

Doctors at the City International Hospital in HCM City have successfully performed surgery on an 18-year-old male patient ...

Research is constantly evolving in the world of cognitive health, including for neurological diseases for which there are ...

The project is dedicated to safeguarding US vaccine use so that it remains grounded in the best available science, free from ...